with reported rates of 1 apoptotic cardiomyocyte in 10,000-100,000. 20 Apoptosis is strikingly increased and plays a significant pathophysiological role in the clinical cardiomyopathies and in experimental models of HF or hypertrophy decompensation. [21] [22] [23] [24] [25] [26] [27] [28] In human failing hearts in NYHA classes III-IV, apoptotic cells are observed in the range of 0.12-0.70%. 29 Recently, multiple stimuli for cardiomyocyte cell death have been identified, including excessive stretch, reactive oxygen species (ROS), 1 adrenergic receptor agonists, angiotensin II, proinflammatory cytokines and cytoskeletal derangements. ROS are involved in a wide variety of cellular functions, including apoptosis. Apoptosis signal-regulating kinase 1 (ASK1) is an ROS-sensitive mitogen-activated protein (MAP) kinase kinase kinase and activates both p38 and c-Jun N-terminal kinase (JNK) pathways by directly phosphorylating and activating MAP kinase kinase (MKK) 4/MKK7 and MKK3/MKK6. 30 The ASK1/JNK pathway can inactivate Bcl-2, mediated by its phosphorylation. 31 We previously reported that the ROS-ASK1-JNK pathway plays an important role in apoptosis in the heart. 32 ASK1 is activated in pressure overloaded and postinfarcted mouse hearts, and ASK1-deficient mice have attenuated cardiac remodeling. The JNK phosphorylation level is significantly increased in pressure overloaded and postinfarcted wildtype mouse hearts. However, the increases in the phosphorylation level of JNK are significantly attenuated in ASK1-deficient mouse hearts. The number of TUNEL (terminal deoxynucleotidyl transferase biotin-dUDP nick end-labeling)-positive myocytes after pressure overload or myocardial infarction is decreased in ASK1-deficient mice compared with wild-type mice. Overexpression of a constitutively active mutant of ASK1 induces apoptosis in isolated rat neonatal cardiomyocytes, whereas neonatal ASK1-deficient cardiomyocytes are resistant to H2O2-induced apoptosis. Thus, the ASK1-JNK pathway plays a pivotal role in regulating left ventricular remodeling by promoting apoptosis, and it has been suggested that inhibition of ASK1 is beneficial for preventing HF.
We also reported that chronic inhibition of ASK1 activation by transcoronary gene transfer using recombinant adeno-associated virus can attenuate the progression of cardiac remodeling in TO-2 cardiomyopathic hamsters. 33 Inhibition of ASK1 reduces the number of apoptotic cells and selectively attenuates JNK activation. Thus, suppression of ASK1 may constitute a novel therapeutic strategy for the treatment of patients with HF. On the other hand, we have reported that the phosphorylation of p38, which is also downstream of ASK1, is increased to a similar degree in both wild-type mice and ASK1-deficient mice after pressure overload or myocardial infarction. 32 We have also reported that p38 plays a critical role in the cardiomyocyte survival pathway. 34 In response to pressure overload to the left ventricle, cardiac-specific p38 -deficient mice developed cardiac dysfunction and heart dilatation, accompanied by massive cardiac fibrosis and the appearance of apoptotic cardiomyocytes. These findings suggest that other, not yet identified, MAP kinase kinase kinases can activate p38 and promote cell survival mechanisms.
Necrosis
Necrosis is classically characterized by early plasma membrane rupture and dilatation of cytoplasmic organelles, in particular the mitochondria. 35, 36 Necrosis is often defined in a negative manner, as death lacking the characteristics of programmed cell death and thus accidental and uncontrolled. 37 However, it has recently become clear that necrotic cell death is well controlled and programmed. Mitochondria play an important role in energy production, Ca 2+ homeostasis and cell death.
Mitochondrial membrane permeability transition (MPT), also known as mitochondrial depolarization, is defined as the loss of transmembrane potential of the mitochondrial inner membrane and is a regulated Ca 2+ -dependent increase in the permeability of the mitochondrial membrane. 38, 39 MPT leads to the loss of the proton gradient and the shutdown of ATP generation through oxidative phosphorylation, resulting in mitochondrial swelling and the rupture of the outer membrane. Thus, MPT is considered to be a key event and is thought to occur after the opening of a putative channel complex, which has been termed the permeability transition pore and which consists of the voltage-dependent anion channel, the adenine nucleotide translocator (ANT), cyclophilin D (CypD) and other molecules. 40, 41 Permeability transition pores open in the mitochondrial inner membrane in response to stimuli such as increased intracellular Ca 2+ , inorganic phosphate, alkaline pH, and ROS. Because MPT still occurs in the ANT-deficient mitochondria in response to several MPT inducers, such as calcium ionophores, ANT may not be essential for MPT. 42 CypD is a cyclophilin family of peptidyl prolyl-cis, trans-isomerases 43 and a structural component of the MPT pore. 40 CypD resides in the mitochondrial matrix, but associates with the inner mitochondrial membrane during MPT.
Oxidative stress has been implicated in necrotic cell death in cardiac pathologies such as ischemia -reperfusion (IR) injury 44 and HF. 45 Oxidative stress-induced necrosis is considered to be caused by MPT pore opening and ATP depletion. 46, 47 Recently, CypD-deficient mice showed a high level of resistance to IR-induced cardiac injury. 44 In control hearts, IR injury caused significant necrotic damage, but in CypD deficient hearts, the infarct area was dramatically reduced. Consistently, lactate dehydrogenase release is almost completely inhibited in CypD-deficient hearts. The CypD-dependent MPT regulates some forms of necrotic death, but not apoptotic death, by using CypD-deficient mitochondria and cells. These findings suggest that Cyp-D-mediated MPT is a key effector of cellular necrosis. Several pharmacological agents, in particular cyclosporine A (CsA), can inhibit the loss of mitochondrial membrane potential. 48 The mitochondrial target of CsA is CypD. However, CsA also inhibits calcineurin; for example, loss of calcineurin activity enhances apoptotic cell loss in the heart. 49 Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis mediated through CypD attenuates muscular dystrophy. 50 Thus, the CsA analogs that do not inhibit calcineurin might be advantageous for attenuating MPT and the loss of cells by necrosis in select forms of HF. 45 Using ASK1-deficient mice, we found that ASK1 is involved in necrosis, as well as apoptosis, and that ASK1-dependent necrosis is likely to contribute to myocardial cell death in the IR heart. 51 In control hearts, IR injury causes significant necrotic damage; however, the infarct area is dramatically reduced in ASK1-deficient hearts. The mechanism of ASK1-dependent necrosis remains to be elucidated. degradation and recycling of cytoplasmic components, such as long-lived proteins and organelles. In a nutrient-deprived cell, autophagy is a cell-survival mechanism. [52] [53] [54] There are 3 main autophagic pathways: macroautophagy, 55,56 microautophagy 57 and chaperon-mediated autoghagy. 58 The term "autophagy" refers to macro-autophagy, unless otherwise specified. Autophagy involves sequestration of cytosolic constituents, including proteins and organelles, in autophagosomes and degradation in lysosomes. Autophagy is controlled by autophagy-related genes, many of which are involved in autophagosome formation. In general, autophagy is thought to be a non-selective degradation system. This feature is in marked contrast to the ubiquitin -proteasome system, which specifically recognizes only ubiquitinated proteins for proteasomal degradation. Recent studies have demonstrated a variety of physiological and pathophysiological roles in autophagy, such as adaptation to nutrient deprivation, intracellular clearance of protein and organelles, development, anti-aging, elimination of microorganisms, cell death, tumor suppression, and antigen presentation. Autophagy appears to modulate both cell viability and death. 59, 60 Autophagy has been observed in both hypertrophied myocardium 61 and failing myocardium caused by dilated cardiomyopathy, 4,62,63 valvular disease 64 and ischemic heart disease. [65] [66] [67] In patients with terminal HF secondary to ischemic cardiomyopathy or dilated cardiomyopathy, cellular degeneration with granular cytoplasmic ubiquitin inclusion is detected in 0.3% of the cardiomyocytes. 62 Human failing hearts with idiopathic dilated cardiomyopathy exhibited morphological features of autophagic, apoptotic and necrotic cells. 4 In human hibernating myocardium, degenerated cardiomyocytes with autophagic vacuoles and nuclear disassembly are also observed. 66 Cardiomyocytes obtained from a UM-X7.1 hamster model of human dilated cardiomyopathy contain typical autophagic vacuoles, including degraded mitochondria, glycogen granules, and myelin-like figures. 68 Degenerated cardiomyocytes showing characteristics of autophagy have also been observed in diphtheria toxin receptor transgenic mice. 69 However, it remains unclear whether autophagy is a sign of failed cardiomyocyte repair or is a suicide pathway for failing cardiomyocytes.
In genetically engineered cell lines and mice, autophagy appears to play a protective role in cardiomyocytes. Enhancing autophagy by beclin-1 overexpression reduces Bax activation and protects against IR injury in cardiac HL-1 cells. 70 LAMP2-deficient mice show excessive accumulation of autophagic vacuoles and impaired autophagic degradation of long-lived proteins, resulting in cardiomyopathy. 71, 72 We have also reported that temporally controlled, cardiacspecific, Atg5-deficiency in tamoxifen-treated Atg5 flox/flox ; MerCreMer + mice leads to left ventricular dilatation and contractile dysfunction. 73 These results indicate that autophagy plays a beneficial role in the heart, because inactivation of Atg5 causes the accumulation of abnormal proteins and organelles and promotes endoplasmic reticulum (ER) stress and apoptosis. Accumulation of abnormal proteins and organelles, especially mitochondria, may directly cause cardiac dysfunction.
Because cardiac-specific Atg5-deficiency during the early stages of cardiogenesis does not cause aberrant cardiac phenotypes under normal physiologic conditions, we have examined the role of autophagy in the heart during sustained pressure overload. In wild-type mice, pressure overload because of transverse aortic constriction (TAC) induces hypertrophy 1 week after TAC and HF 4 weeks after TAC. 32 Cardiac-specific Atg5 deficiency in Atg5 flox/flox ; MLC2v-Cre + mice causes cardiac dysfunction and left ventricular dilatation 1 week after TAC. 73 Polyubiquitinated proteins accumulate, ER stress is increased and apoptosis is promoted in Atg5-deficient hearts. Four weeks after TAC, autophagy is upregulated in failing wild-type hearts. These results indicate that constitutive autophagy in the heart under baseline conditions is a homeostatic mechanism for maintaining cardiomyocyte size and global cardiac structure and function, and that upregulation of autophagy in the failing heart is an adaptive response that protects cells from hemodynamic stress. 73 Autophagy may be protective during ischemia, but may be detrimental during reperfusion. 74 Autophagy is induced by ischemia and is further enhanced by reperfusion. Autophagy resulting from ischemia is accompanied by AMP-activated protein kinase (AMPK) activation and is inhibited by dominant-negative AMPK. In contrast, autophagy during reperfusion is accompanied by upregulation of beclin-1 but not by activation of AMPK. Induction of both autophagy and cardiac injury during IR are attenuated in heterozygous beclin-1-deficient mice, accompanied by a decrease in apoptosis. 74 
Crosstalk Between Apoptosis, Necrosis and Autophagy
Autophagy seems to be required to (1) increase protein turnover, (2) remove damaged organelles such as mitochondria undergoing MPT, which is defined as the loss of transmembrane potential of the mitochondrial inner membrane, and (3) maintain ER as a cytoprotective mechanism. With increasing stress, pro-apoptotic factors are released from mitochondria undergoing MPT. In particular, in the absence of autophagy, the accumulation of polyubiquitinated proteins may be responsible for increased ER stress, resulting in apoptosis. Excessive autophagic activity induced by severe stimuli can destroy a large fraction of the cytosol and organelles and release lysosomal enzymes and possibly other factors that promote cell death, leading to apoptotic cell death. Under extreme stress, MPT occurs in all mitochondria and the intracellular supply of ATP is exhausted, leading to necrotic cell death. Thus, the dead and dying cells can simultaneously show characteristics of autophagy, apoptosis and necrosis. 4 Recent reports have demonstrated crosstalk between the apoptotic, necrotic and autophagic pathways. Several signaling pathways that are induced by common cellular stressors regulate both autophagy and apoptosis. ROS not only trigger apoptosis, 32 but are also essential for autophagy and specifically regulate Atg4 activity. 75 Increases in the cytosolic-free Ca 2+ concentration not only activate pro-apoptotic signals, 76 but also potently induce autophagy by activating calmodulin-dependent kinase kinase. 77 Members of the beclin-1 and Bcl-2 family serve as a point of crosstalk between the autophagic and apoptotic pathways. Beclin 1, which is a mammalian autophagy gene, 78 was originally identified as a Bcl-2 interacting protein. 79 Beclin-1 directly interacts not only with Bcl-2 but also with other anti-apoptotic Bcl-2 family proteins such as Bcl-xL. 80 Bcl-2 inhibits beclin-1-dependent autophagy in yeast and mammalian cells. Cardiac Bcl-2 transgenic expression also inhibits autophagy in murine heart cells. Bcl-2 inhibits the formation of the beclin-1/Vsp34 PI3 kinase complex and beclin-1-associated class III PI3 kinase activity. 80 UVRAG is a positive, and Bcl-2 a negative, regulator of the beclin-1-class III PI3 kinase complex. Under stressed conditions, Bcl-2 weakly associates with the beclin-1-class III PI3 kinase complex, whereas UVRAG remains in the complex, resulting in amplified autophagy. 81 Although HSpin1, the human ortholog of Drosophila Spin-induced cell death, is characteristic of autophagic cell death, HSpin1 binds to Bcl-2 and Bcl-xL. 82 Overexpression of Bcl-xL inhibits HSpin1-induced cell death. A necrosis inhibitor, pyrrolidine dithiocarbonate, blocks HSpin1-induced cell death, whereas the pancaspase inhibitors, carbobenzoxy-VAD-fluoromethyl ketone and p35 do not.
Conclusions
HF is preceded by cardiac remodeling, which involves increased rates of cardiomyocyte cell death. Much recent research has focused on the mechanisms of cardiomyocyte cell death in HF. Lethal stresses, such as pressure overload and ischemic insult, activate intracellular signal transduction pathways, resulting in an imbalance of survival and cell death, and lead to apoptosis and/or necrosis and HF (Fig 1) . In the future, potential therapeutic targets to prevent the progression of cardiac remodeling and HF will be identified.
